Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)

This study has been completed.
BioMarin Pharmaceutical
Information provided by (Responsible Party):
University of Missouri-Columbia Identifier:
First received: August 21, 2009
Last updated: October 21, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)